To ask the Secretary of State for Environment, Food and Rural Affairs, what steps he is taking to support the development of a vaccine for cattle to prevent the spread of bovine TB.
Answered on
9 September 2020
Developing a TB vaccine for cattle is one of the Government’s priorities. A cattle vaccine could be a game-changer in terms of providing a strong additional tool to help eradicate bovine TB.
In July 2020, we announced that the Veterinary Medicines Directorate (VMD) had granted permission for field trials of both the candidate Cattle BCG vaccine and the candidate skin test to differentiate infected from vaccinated animals (the DIVA skin test).
Like other veterinary medicines, both the Cattle BCG vaccine and the DIVA skin test will need VMD marketing authorisations before they can be deployed.
It is hoped that field trials will provide the evidence required for future marketing authorisations and for the DIVA skin test to be internationally recognised. The aim is to start field trials in 2021 and complete them in 2024.
Provided the field trials go as hoped, and VMD considers the marketing authorisation applications satisfactory with respect to quality, safety and efficacy, the timeline envisages those authorisations being granted in 2025.